netFormulary NHS
NHS BaNES CCG, NHS Swindon CCG, NHS Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust

Welcome to the BaNES, Swindon and Wiltshire Joint Formulary
For use by primary, secondary & community care prescribers within BaNES, Swindon & Wiltshire
See about page for information relating to the three formularies which have merged to make this
new BSW joint formulary and for traffic light definitions.

To use this formulary, search by medicine name, condition [use search box below] or BNF chapter/subsection [use chapter tab]. For further information see QRG - how to use BSW formulary website and QRG - how to use BSW formulary App

Useful Links


Prescribing Guidelines 

Shared Care Guidance

BSW Management of infections in Primary Care
*Regularly updated - we suggest not printing*
Full Guideline
Quick Ref Guide adults Quick Ref Guide children

BaNES CCG Medicines Management Information

Swindon CCG Medicines Management Information

Wiltshire CCG Medicines Management Information 

Royal United Hospitals Bath NHS Foundation Trust intranet link

Great Western Hospitals NHS Foundation Trust intranet link

Salisbury NHS Foundation Trust [link coming soon]


PRIMARY CARE - to reduce pressures on the medicines supply chain nationally, please use eRD, keeping the quantity the same. User guide can be found here.

27/03/2020 - There will be a NICE Rapid Review of antimicrobial prescribing in patients with suspected COVID-19 published (hopefully in next 7 days). No significant changes in antimicrobial prescribing should be undertaken in this patient cohort in the meantime.

As COVID-19 escalates, national groups for specific medical conditions will put out statements to support their patient groups. The following is not an exhaustive list, and will be updated in time. **Please note all of the resources signposted from here are freely available on the internet. Inclusion here does not indicate the statement has been agreed locally unless specifically stated**

Ear Nose and Throat UK - loss of sense of smell as marker for COVID-19 


COVID-19 infection and pregnancy


Position Statement of the ESC Council on Hypertension on ACE-I and ARBs

BSH & BCS Joint statement on ACEi or ARB in relation to COVID-19


BSG/RCP Advice for IBD & Liver clinicians on identifying immunosuppressed patients for shielding 

COVID-19: BSG and BASL advice for HCPs in Gastroenterology and Hepatology

interview COVID-19 ECCO Taskforce (Gastroenterologists)


Kidney Care UK COVID-19 guidance for patients with kidney disease


International Psoriasis Council Statement On COVID-19

BAD statement - Covid-19: interim advice for those taking medicines that affect the immune system


Statement for patients with adrenal pituitary insufficiency

Diabetes UK - COVID-19 – advice for people living with diabetes  

Children/young people T1 diabetes  


BSR - Covid-19 - update for members

MHRA alert addressing recent concern about the use of NSAIDs in relation to Covid-19.


Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers 

ABN Guidance on Disease Modifying Therapies for MS and COVID19

Stroke Association - People affected by Stroke  


Asthma UK Covid-19 health advice for people with asthma

British Lung Foundation Information on COVID-19


Also see Primary Care Pathways for many more useful links including Clinical Assessment, Practice Management Plans, Further Resources for Patients and Resources to Support GP Remote Working  **Please note all of the resources signposted from here are freely available on the internet. Inclusion here does not indicate the resource or pathway has been agreed locally unless specifically stated**


News Feed

- Covid-19: Guidance for the public here.
- Covid-19: Guidance for HCPs here.

During the Covid-19 outbreak, clinicians in England should submit reports of suspected side effects to medicines or medical devices using the Yellow Card Scheme electronically (rather than by paper) via the Yellow Card website or the free Yellow Card app [from the Apple App Store or Google Play Store] to enable early identification of trends.

25th March 2020 - MHRA statement on cloroquine and hydroxychloroquine for COVID-19 - Until we have clear, definitive evidence that these treatments are safe and effective for the treatment of COVID-19, chloroquine and hydroxychloroquine should only be used for this purpose within a clinical trial

27 Mar 2020 - Safe switching of warfarin to DOACs for patients with NVAF and VTE (DVT / PE) during the coronavirus pandemic 

Mar 2020 - Ulipristal (Esmya) removed from formulary: suspension of license due to risk of serious liver injury 

Mar 2020 - MHRA DSU Tofacitinib (Xeljanz▼): new measures to minimise risk of VTE and of serious and fatal infections

Mar 2020 - MHRA DSU Baricitinib (Olumiant▼): risk of venous thromboembolism

>>> more news

Website constantly under development. Report inaccuracies/feedback at

A number of ‘differences’ in formulary options, traffic light statuses, prescribing guidelines and shared care protocols have yet to be agreed across BSW. Please bear with us as we work to review these and please follow the guidance for your locality.

The formulary is intended to be used when prescribing for adolescents and adults. 

All material on this website is aimed at healthcare professionals working in BaNES, Swindon and Wiltshire, but is information currently held within the public domain.

Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or out of hours contact the NHS 111 service by telephoning 111.

   Visits = 36315
   Last updated: 01/04/2020 16:48:01..
    Download net formulary from Apple IOS Store  Google Play net formulary